• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

截断的 tau 蛋白在人类 tau 病的大鼠模型中扰乱了突触标记物。

Truncated tau deregulates synaptic markers in rat model for human tauopathy.

机构信息

Institute of Neuroimmunology, Slovak Academy of Sciences Bratislava, Slovak Republic.

Axon Neuroscience GmbH Bratislava, Slovak Republic ; Institute of Mathematics and Statistics, Masaryk University Brno, Czech Republic.

出版信息

Front Cell Neurosci. 2015 Feb 23;9:24. doi: 10.3389/fncel.2015.00024. eCollection 2015.

DOI:10.3389/fncel.2015.00024
PMID:25755633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4337338/
Abstract

Synaptic failure and neurofibrillary degeneration are two major neuropathological substrates of cognitive dysfunction in Alzheimer's disease (AD). Only a few studies have demonstrated a direct relationship between these two AD hallmarks. To investigate tau mediated synaptic injury we used rat model of tauopathy that develops extensive neurofibrillary pathology in the cortex. Using fractionation of cortical synapses, we identified an increase in endogenous rat tau isoforms in presynaptic compartment, and their mis-sorting to the postsynaptic density (PSD). Truncated transgenic tau was distributed in both compartments exhibiting specific phospho-pattern that was characteristic for each synaptic compartment. In the presynaptic compartment, truncated tau was associated with impairment of dynamic stability of microtubules which could be responsible for reduction of synaptic vesicles. In the PSD, truncated tau lowered the levels of neurofilaments. Truncated tau also significantly decreased the synaptic levels of Aβ40 but not Aβ42. These data show that truncated tau differentially deregulates synaptic proteome in pre- and postsynaptic compartments. Importantly, we show that alteration of Aβ can arise downstream of truncated tau pathology.

摘要

突触衰竭和神经纤维变性是阿尔茨海默病(AD)认知功能障碍的两个主要神经病理学基础。只有少数研究表明这两个 AD 标志物之间存在直接关系。为了研究 tau 介导的突触损伤,我们使用了在皮质中形成广泛神经纤维病理的 tau 病大鼠模型。通过皮质突触的分段,我们在突触前区发现内源性大鼠 tau 异构体增加,并错误地分类到突触后密度(PSD)。截断的转基因 tau 分布在两个区室中,表现出每个突触区室特有的特定磷酸化模式。在突触前区室中,截断的 tau 与微管的动态稳定性受损有关,这可能是突触小泡减少的原因。在 PSD 中,截断的 tau 降低了神经丝的水平。截断的 tau 还显著降低了突触水平的 Aβ40,但不降低 Aβ42。这些数据表明,截断的 tau 在突触前和突触后区室中差异地上调了突触蛋白质组。重要的是,我们表明 Aβ 的改变可能是截断的 tau 病变的下游结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/d14322e2e4d9/fncel-09-00024-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/e630b8aa885c/fncel-09-00024-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/a3326b7e24e7/fncel-09-00024-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/d0bf260c8ac5/fncel-09-00024-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/88605046ea6c/fncel-09-00024-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/6bf8f5f9020f/fncel-09-00024-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/818a40c670a3/fncel-09-00024-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/3f99d15d2f4f/fncel-09-00024-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/d14322e2e4d9/fncel-09-00024-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/e630b8aa885c/fncel-09-00024-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/a3326b7e24e7/fncel-09-00024-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/d0bf260c8ac5/fncel-09-00024-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/88605046ea6c/fncel-09-00024-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/6bf8f5f9020f/fncel-09-00024-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/818a40c670a3/fncel-09-00024-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/3f99d15d2f4f/fncel-09-00024-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9112/4337338/d14322e2e4d9/fncel-09-00024-g0008.jpg

相似文献

1
Truncated tau deregulates synaptic markers in rat model for human tauopathy.截断的 tau 蛋白在人类 tau 病的大鼠模型中扰乱了突触标记物。
Front Cell Neurosci. 2015 Feb 23;9:24. doi: 10.3389/fncel.2015.00024. eCollection 2015.
2
Tau-mediated synaptic damage in Alzheimer's disease.阿尔茨海默病中tau蛋白介导的突触损伤
Transl Neurosci. 2015 Oct 23;6(1):214-226. doi: 10.1515/tnsci-2015-0023. eCollection 2015.
3
Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease.在阿尔茨海默病中,突触前C末端截短的tau蛋白从皮质突触中释放出来。
J Neurochem. 2015 May;133(3):368-79. doi: 10.1111/jnc.12991. Epub 2015 Jan 13.
4
A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.AD 突触处的一个 NH2 端 tau 片段靶向神经元线粒体:可能对神经退行性变的影响。
J Alzheimers Dis. 2010;21(2):445-70. doi: 10.3233/JAD-2010-100120.
5
First transgenic rat model developing progressive cortical neurofibrillary tangles.首例进展性皮质神经原纤维缠结的转基因大鼠模型。
Neurobiol Aging. 2012 Jul;33(7):1448-56. doi: 10.1016/j.neurobiolaging.2010.10.015. Epub 2010 Dec 31.
6
Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.阿尔茨海默病、帕金森病及相关α-突触核蛋白病中额叶皮质富含突触的组分中tau蛋白和α-突触核蛋白的磷酸化。
Neuroscience. 2008 Apr 9;152(4):913-23. doi: 10.1016/j.neuroscience.2008.01.030. Epub 2008 Feb 5.
7
Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.截短的tau蛋白表达水平决定了tau蛋白病大鼠模型的寿命,而不会导致神经元丢失,也与终末期神经原纤维缠结负荷无关。
Eur J Neurosci. 2008 Jul;28(2):239-46. doi: 10.1111/j.1460-9568.2008.06329.x.
8
5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy.5-羟色胺4(5-HT4)受体激动剂治疗可减轻tau蛋白病PS19小鼠模型中的tau病理变化和行为缺陷。
Front Cell Neurosci. 2024 Apr 4;18:1338502. doi: 10.3389/fncel.2024.1338502. eCollection 2024.
9
Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.散发性阿尔茨海默病中的截短型tau蛋白足以在体内引发神经原纤维变性。
FEBS Lett. 2006 Jun 26;580(15):3582-8. doi: 10.1016/j.febslet.2006.05.029. Epub 2006 May 22.
10
A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.一种由天然启动子驱动表达双突变tau的新型转基因小鼠表现出tau蛋白病特征。
Exp Neurol. 2008 Jul;212(1):71-84. doi: 10.1016/j.expneurol.2008.03.007. Epub 2008 Mar 21.

引用本文的文献

1
Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer's disease: A meta-analysis 2015-2023.阿尔茨海默病动物模型中突触前蛋白的蛋白质组学和非蛋白质组学变化:2015 - 2023年的一项荟萃分析
J Alzheimers Dis. 2025 Aug 1;107(2):13872877251362212. doi: 10.1177/13872877251362212.
2
Alzheimer's Disease Protein Targets: Comprehensive Review and Future Directions.阿尔茨海默病的蛋白质靶点:综述与未来方向
Curr Pharm Des. 2025;31(17):1347-1369. doi: 10.2174/0113816128334916241006195142.
3
Tau truncation in the pathogenesis of Alzheimer's disease: a narrative review.

本文引用的文献

1
Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer's disease.确定tau蛋白对其病理功能至关重要的结构决定因素:阿尔茨海默病中tau免疫疗法的新型治疗靶点。
Alzheimers Res Ther. 2014 Aug 1;6(4):45. doi: 10.1186/alzrt277. eCollection 2014.
2
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.天冬酰胺内肽酶介导的 tau 裂解介导阿尔茨海默病的神经纤维病理。
Nat Med. 2014 Nov;20(11):1254-62. doi: 10.1038/nm.3700. Epub 2014 Oct 19.
3
Biochemical Distribution of Tau Protein in Synaptosomal Fraction of Transgenic Mice Expressing Human P301L Tau.
Tau蛋白截短在阿尔茨海默病发病机制中的作用:一篇叙述性综述
Neural Regen Res. 2024 Jun 1;19(6):1221-1232. doi: 10.4103/1673-5374.385853. Epub 2023 Sep 22.
4
Pathological Impact of Tau Proteolytical Process on Neuronal and Mitochondrial Function: a Crucial Role in Alzheimer's Disease.tau 蛋白水解过程对神经元和线粒体功能的病理影响:在阿尔茨海默病中的关键作用。
Mol Neurobiol. 2023 Oct;60(10):5691-5707. doi: 10.1007/s12035-023-03434-4. Epub 2023 Jun 19.
5
Activity-dependent tau cleavage by caspase-3 promotes neuronal dysfunction and synaptotoxicity.由半胱天冬酶-3介导的依赖活性的tau蛋白切割会促进神经元功能障碍和突触毒性。
iScience. 2023 May 19;26(6):106905. doi: 10.1016/j.isci.2023.106905. eCollection 2023 Jun 16.
6
Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies.阿尔茨海默病和其他 Tau 病中的磷酸化 Tau。
Int J Mol Sci. 2022 Oct 25;23(21):12841. doi: 10.3390/ijms232112841.
7
Enriched environment ameliorates propagation of tau pathology and improves cognition in rat model of tauopathy.丰富环境改善tau蛋白病大鼠模型中tau病理的传播并改善认知。
Front Aging Neurosci. 2022 Jul 26;14:935973. doi: 10.3389/fnagi.2022.935973. eCollection 2022.
8
Natural Bioactive Products and Alzheimer's Disease Pathology: Lessons from Transgenic Models.天然生物活性产物与阿尔茨海默病病理学:转基因模型的启示
Diseases. 2022 May 13;10(2):28. doi: 10.3390/diseases10020028.
9
Hyperphosphorylated Human Tau Accumulates at the Synapse, Localizing on Synaptic Mitochondrial Outer Membranes and Disrupting Respiration in a Mouse Model of Tauopathy.在tau蛋白病小鼠模型中,过度磷酸化的人tau蛋白在突触处积累,定位于突触线粒体外膜并破坏呼吸作用。
Front Mol Neurosci. 2022 Mar 10;15:852368. doi: 10.3389/fnmol.2022.852368. eCollection 2022.
10
Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly.靶向 tau 仅细胞外可能不如靶向细胞内外都更有效。
Semin Cell Dev Biol. 2022 Jun;126:125-137. doi: 10.1016/j.semcdb.2021.12.002. Epub 2021 Dec 9.
转染 P301L 人 Tau 蛋白的转基因小鼠突触体部分 Tau 蛋白的生化分布。
Front Neurol. 2014 Mar 11;5:26. doi: 10.3389/fneur.2014.00026. eCollection 2014.
4
Synaptic and sub-synaptic localization of amyloid-β protein precursor in the rat hippocampus.大鼠海马体中淀粉样β蛋白前体的突触及亚突触定位
J Alzheimers Dis. 2014;40(4):981-92. doi: 10.3233/JAD-132030.
5
The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system.阿尔茨海默病中过度磷酸化 tau 寡聚物的突触积累与泛素-蛋白酶体系统功能障碍有关。
Am J Pathol. 2012 Oct;181(4):1426-35. doi: 10.1016/j.ajpath.2012.06.033. Epub 2012 Aug 4.
6
Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation.内源性 tau 蛋白与突触蛋白的相互作用受 N-甲基-D-天冬氨酸受体依赖性 tau 磷酸化调节。
J Biol Chem. 2012 Sep 14;287(38):32040-53. doi: 10.1074/jbc.M112.401240. Epub 2012 Jul 25.
7
Neuropathological alterations in Alzheimer disease.阿尔茨海默病的神经病理学改变。
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006189. doi: 10.1101/cshperspect.a006189.
8
Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease.阿尔茨海默病中病理性 Aβ42:Aβ40 比值增加毒性的结构基础。
J Biol Chem. 2012 Feb 17;287(8):5650-60. doi: 10.1074/jbc.M111.264473. Epub 2011 Dec 8.
9
Wnt7a signaling promotes dendritic spine growth and synaptic strength through Ca²⁺/Calmodulin-dependent protein kinase II.Wnt7a 信号通过 Ca²⁺/钙调蛋白依赖性蛋白激酶 II 促进树突棘生长和突触强度。
Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10732-7. doi: 10.1073/pnas.1018132108. Epub 2011 Jun 13.
10
Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice.在tau 病模型小鼠的伏隔核中,磷酸化 tau 和突触丢失的差异区域性分布。
Neurobiol Dis. 2011 Jun;42(3):404-14. doi: 10.1016/j.nbd.2011.02.002. Epub 2011 Feb 13.